Half of all women with HIV are diagnosed late in Europe
Many women in the WHO European Region, particularly those in their 40s, are diagnosed at a late stage of HIV infection when their immune system is already starting to fail. They are three to four times more likely to be diagnosed late than younger women. According to data for 2018 released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe, women accounted for one-third of the 141 000 new HIV diagnoses in the Region, indicating that this population needs more attention in Europe's prevention and testing efforts.
Every hour 30 people are diagnosed with tuberculosis in the European Region. It’s time to make TB a disease of the past
The latest ECDC/WHO report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a major public health challenge in the Region.
Zoonoses: antimicrobial resistance shows no signs of slowing down
Data released today by the European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.
Zoonotic diseases: progress has stalled
There were only minor fluctuations in reported cases of three main zoonotic diseases in the European Union (EU) last year compared with 2016.
New HIV diagnoses at alarmingly high levels in the European Region despite progress in EU/EEA
With nearly 160 000 people newly diagnosed with HIV, 2017 marked another year of alarming numbers of new HIV diagnoses in the WHO European Region. In contrast, the European Union and European Economic Area (EU/EEA) countries reported a decline in rates of new diagnoses, mainly driven by a 20% decrease since 2015 among men who have sex with men.
ECDC calls for continued action to address antimicrobial resistance in healthcare settings
On European Antibiotic Awareness Day, ECDC publishes the results of two point-prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and in long-term care facilities in the EU/EEA.
Press release: 4% annual decrease too slow to end TB by 2030 – call for Europe’s commitment to increase investment to end TB
A new report published today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe indicates that the number of new tuberculosis (TB) patients has been decreasing at an average rate of 4.3% per year in the WHO European Region over the last decade.
Antimicrobial resistance in zoonotic bacteria still high in humans, animals and food, say ECDC and EFSA
Bacteria from humans and animals continue to show resistance to antimicrobials, according to a new report published today by the European Food Safety Authority and the European Centre for Disease Prevention and Control. The report highlights some emerging issues and confirms antimicrobial resistance as one of the biggest threats to public health. AMR reduces the effectiveness of treatment options.